Host – Christopher Floyd, Executive Medical Director, tranScrip

Roz Sutton, Regulatory Expert, tranScrip

Christopher Floyd, Executive Medical Director at tranScrip, joins Roz Sutton, Regulatory Expert, to discuss how aligning regulatory and medical expertise can de-risk drug development. They explore why early regulatory strategy matters, how medical rationale strengthens decision-making, and why collaboration and clarity are essential in an evolving regulatory landscape.